glp-1 drugs key developments 2025 Clinical Practice Updates: December GLP-1 Weight-Loss Drugs Ride Health,

However, long-term human safety data remains limited

For long term storage, add 0.1% w/v carrier protein such as recombinant human serum albumin (HSA) and avoid repeated freeze-thaw cycles by aliquoting

and Phenylalanine, Methylfolate and S-Adenosyl-Methionine (SAMe) for neurotransmitter and dopamine support

Astrocyte interferon-gamma signaling dampens inflammation during chronic central nervous system autoimmunity via PD-L1

Aside from painless administration, MN arrays provide numerous advantages, including the absence of bleeding, controlled drug release, minimal pathogen introduction, reduction in transdermal dosage variability of small compounds, and concerns associated with infections [266, 271, 272]